Hoping to lose weight? Intermittent fasting might be worth trying - Two in five U.S. adults are living with obesity ...

With his majority opinion in Mahmoud v. Taylor, Alito gave bigoted parents a big, fat kiss—and changed the nature of public ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

The Trump administration's decision to fire the CDC team whose job it was to provide clinical guidelines on how to safely ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Investigating smoking cessation and waist circumference, this study highlights the role of leisure-time physical activity in ...

Discover how sarcopenic obesity affects 23% of people through hidden muscle loss and fat gain, plus treatment options.

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...